The Unit comprises statisticians, clinical trial experts, epidemiologists, clinical academics and researchers focussing on methods for cancer prevention.
Our research portfolio includes CRUK funded trials for endocrine prevention of breast cancer, a CRUK Catalyst award to determine how aspirin prevents cancer, and studies of HPV testing approaches (especially self-sampling) for cervical screening. We undertake studies related to population-based germline testing, for risk prediction, stratification, targeted screening and cancer prevention; evaluating mainstreaming genetic testing approaches at cancer diagnosis; management of increased risk; and studies to improve surgical prevention of gynaecological cancers. We also work on health economic analysis in the above areas.
Prof. Jack Cuzick
Dr. Belinda Nedjai
Alex Ferrell, email@example.com